Accès ouvert
2023
article
OpenAlex
Maria R. Farcet, Jens Modrof, Gerhard Antoine, Cecilie Klausen et autres
Minute virus of mice (MMV) has contaminated biotechnological processes in the past and specific MMV testing is therefore recommended, if the production cell line is known to be permissive for this virus. Testing is widely done using cell-culture-based adventitious virus assays, yet …
at, us
(code pays fourni par la source)
Accès ouvert
2023
other
OpenAlex
Filza Hussain, Michael Freissmuth, Dirk Völkel, Michael Thiele et autres
Abstract Macrophage migration inhibitory factor (MIF) is a proinflammatory cytokine, originally discovered for its eponymous effect and now known for pleiotropic biologic properties in immunology and oncology. Circulating MIF levels are elevated in several types of human cancer including prostate cancer. MIF …
Accès ouvert
2023
supplementary-materials
OpenAlex
Filza Hussain, Michael Freissmuth, Dirk Völkel, Michael Thiele et autres
PDF file - 247K, Suppl. Fig. 1. Pharmacokinetics of BaxG03 after intravenous and intraperitoneal injection; Suppl. Fig. 2. Trough plasma concentrations of BaxG03 after 28 days of administration; Suppl. Fig. 3. Dose-dependent inhibition of xenograft outgrowth by BaxB01 and BaxM159.
Accès ouvert
2023
supplementary-materials
OpenAlex
Filza Hussain, Michael Freissmuth, Dirk Völkel, Michael Thiele et autres
PDF file - 247K, Suppl. Fig. 1. Pharmacokinetics of BaxG03 after intravenous and intraperitoneal injection; Suppl. Fig. 2. Trough plasma concentrations of BaxG03 after 28 days of administration; Suppl. Fig. 3. Dose-dependent inhibition of xenograft outgrowth by BaxB01 and BaxM159.
Accès ouvert
2023
other
OpenAlex
Filza Hussain, Michael Freissmuth, Dirk Völkel, Michael Thiele et autres
Abstract Macrophage migration inhibitory factor (MIF) is a proinflammatory cytokine, originally discovered for its eponymous effect and now known for pleiotropic biologic properties in immunology and oncology. Circulating MIF levels are elevated in several types of human cancer including prostate cancer. MIF …
Accès ouvert
2019
article
OpenAlex
Patrice Douillard, Michael Freissmuth, Gerhard Antoine, Michael Thiele et autres
Efficacy, safety, and manufacturability of therapeutic antibodies are influenced by their biopharmaceutical and biophysical properties. These properties can be optimized by library approaches or rationale protein design. Here, we employed a protein engineering approach to modify the variable domain of the light …
at
(code pays fourni par la source)
2017
article
OpenAlex
Anna‐Maria Kapsch, Maria R. Farcet, Gerhard Antoine, Thomas R. Kreil
BACKGROUND: Recently, a quasi-lipid-enveloped (LE) form of the traditionally nonlipid-enveloped (NLE) hepatitis A virus (HAV) was described in human serum and cell culture-derived HAV stocks. This discovery challenges the understanding of HAV reduction in virus clearance studies of plasma products, which were …
at
(code pays fourni par la source)
2015
article
OpenAlex
Maria R. Farcet, Cornelia Lackner, Gerhard Antoine, Philip O. Rabel et autres
BACKGROUND: Hepatitis E virus (HEV) has been transmitted by transfusion of labile blood products and the occasional detection of HEV RNA in plasma pools indicates that HEV viremic donations might enter the manufacturing process of plasma products. To verify the safety margins …
at, us
(code pays fourni par la source)
2013
article
OpenAlex
Christine Lenk, Sabine Unterthurner, Maria Schuster, Markus Weiller et autres
at
(code pays fourni par la source)
2013
article
OpenAlex
Filza Hussain, Michael Freissmuth, Dirk Völkel, Michael Thiele et autres
Macrophage migration inhibitory factor (MIF) is a proinflammatory cytokine, originally discovered for its eponymous effect and now known for pleiotropic biologic properties in immunology and oncology. Circulating MIF levels are elevated in several types of human cancer including prostate cancer. MIF is …
at
(code pays fourni par la source)
Accès ouvert
2012
article
OpenAlex
Randolf J. Kerschbaumer, Manfred Rieger, Dirk Völkel, Didier Le Roy et autres
The macrophage migration inhibitory factor (MIF) is a proinflammatory cytokine that recently emerged as an attractive therapeutic target for a variety of diseases. A diverse panel of fully human anti-MIF antibodies was generated by selection from a phage display library and extensively …
at, ch, de
(code pays fourni par la source)
Accès ouvert
2011
article
OpenAlex
Pauline M. van Helden, Sabine Unterthurner, Corinna Hermann, Maria Schuster et autres
Replacement of the missing factor VIII (FVIII) is the current standard of care for patients with hemophilia A. However, the short half-life of FVIII makes frequent treatment necessary. Current efforts focus on the development of longer-acting FVIII concentrates by introducing chemical and …
at
(code pays fourni par la source)